Desonide

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

18 Suppliers, 8 USDMF, 1 EU WC, 10 NDC API, 14 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

DOSSIERs // Finished Dosage Forms

53 Dossiers, 26 FDA Orange Book, 17 Europe, 2 Canada, 1 South Africa, 7 Listed Dossiers

DRUG PRODUCT COMPOSITION

CREAM;TOPICAL - 0.05%, OINTMENT;TOPICAL - 0.05%, GEL;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 19 BASF, 6 Kerry, 6 Nanjing Well Pharmaceutical, 5 Seppic, 4 Roquette, 4 Microlex e.U, 4 Actylis, 4 Gangwal Chemicals, 1 Finar, 1 Pharm-RX Chemical, 1 Minakem

EXCIPIENTS BY APPLICATIONS

22 Topical, 11 Solubilizers, 9 Coating Systems & Additives, 8 Film Formers & Plasticizers, 6 Emulsifying Agents, 5 Thickeners and Stabilizers, 5 Parenteral, 5 Lubricants & Glidants, 5 Surfactant & Foaming Agents, 5 Co-Processed Excipients, 4 Granulation, 3 Direct Compression, 3 Fillers, Diluents & Binders, 2 API Stability Enhancers, 2 Taste Masking, 2 Controlled & Modified Release

GLOBAL SALES INFORMATION

25 US Medicaid Prescriptions, 22 Finished Drug Prices

MARKET PLACE

7 APIs

7 APIs

PATENTS

3 US Patents, 1 Health Canada Patents

ANALYTICAL SOLUTION(s)

2 USP Standards, 2 Other Ref. Standards

DIGITAL CONTENT

15 News

15 News

List of USP reference standards related to Desonide

Desonide

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

18 Suppliers

8 USDMF

1 EU WC

10 NDC API

14 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Imports

DOSSIERs // Finished Dosage Forms

53 Dossiers

26 FDA Orange Book

17 Europe

2 Canada

1 South Africa

7 Listed Dossiers

DRUG PRODUCT COMPOSITION

CREAM;TOPICAL - 0.05%

OINTMENT;TOPICAL - 0.05%

GEL;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

19 BASF

6 Kerry

6 Nanjing Well Pharmaceutical

5 Seppic

4 Roquette

4 Microlex e.U

4 Actylis

4 Gangwal Chemicals

1 Finar

1 Pharm-RX Chemical

1 Minakem

EXCIPIENTS BY APPLICATIONS

22 Topical

11 Solubilizers

9 Coating Systems & Additives

8 Film Formers & Plasticizers

6 Emulsifying Agents

5 Thickeners and Stabilizers

5 Parenteral

5 Lubricants & Glidants

5 Surfactant & Foaming Agents

5 Co-Processed Excipients

4 Granulation

3 Direct Compression

3 Fillers, Diluents & Binders

2 API Stability Enhancers

2 Taste Masking

2 Controlled & Modified Release

GLOBAL SALES INFORMATION

25 US Medicaid Prescriptions

22 Finished Drug Prices

MARKET PLACE

7 APIs

PATENTS

3 US Patents

1 Health Canada Patents

ANALYTICAL SOLUTION(s)

2 USP Standards

2 Other Ref. Standards

DIGITAL CONTENT

15 News

Desonide

USP

Desonide Impurities Mixture (25 mg)

1173315

N/A

F00340

730

USP

Desonide (250 mg)

GEL;TOPICAL - 0.05% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons